BAYER A.G. (BAYZF)
Clinical trial NCT05348733 updates: 1. completion date: 2027-12-15 → 2026-12-22 2. primary completion date: 2027-09-01 → 2026-11-05
Clinical trial NCT05348733 updates: 1. completion date: 2027-12-15 → 2026-12-22 2. primary completion date: 2027-09-01 → 2026-11-05
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical